Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Cambrex Corporation    CBM

Delayed Quote. Delayed  - 08/30 10:02:01 pm
43.4 USD   +0.44%
08/26 Cambrex to Present at Upcoming Investor Conferences in September
07/28 CAMBREX : posts 2Q profit
07/28 Cambrex Reports Second Quarter 2016 Financial Results
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
08/24/2016 08/25/2016 08/26/2016 08/29/2016 08/30/2016 Date
44.12(c) 43.87(c) 44.02(c) 43.21(c) 43.4(c) Last
621 139 368 177 233 793 931 813 434 636 Volume
-0.83% -0.57% +0.34% -1.84% +0.44% Change
More quotes
Financials ($)
Sales 2016 483 M
EBIT 2016 120 M
Net income 2016 79,8 M
Debt 2016 -
Yield 2016 -
Sales 2017 531 M
EBIT 2017 136 M
Net income 2017 90,9 M
Debt 2017 -
Yield 2017 -
P/E ratio 2016 17,78
P/E ratio 2017 15,71
Capi. / Sales2016 2,88x
Capi. / Sales2017 2,62x
Capitalization 1 389 M
More Financials
Company
Cambrex Corp. engages in the provisio ofproducts, services and technologies to accelerate and improve the development and commercialization of new and generic therapeutics.It supplies its products and services to innovator and generic pharmaceutical companies.Its products include generic and... 
Sector
Pharmaceuticals
Calendar
09/07 | 09:30pmPresentation
More about the company
Surperformance© ratings of Cambrex Corporation
Trading Rating : Investor Rating :
More Ratings
Latest news on CAMBREX CORPORATION
08/26 Cambrex to Present at Upcoming Investor Conferences in September
07/28 CAMBREX : posts 2Q profit
07/28 CAMBREX CORP : Results of Operations and Financial Condition, Financial Statemen..
07/28 CAMBREX : Management's Discussion and Analysis of Financial Condition and Result..
07/28 Cambrex Reports Second Quarter 2016 Financial Results
07/26 Cambrex to Announce Second Quarter 2016 Financial Results on July 28, 2016
07/18 CAMBREX : Charles City expansion project is complete
07/14 CAMBREX : Completes $50 Million Investment in Large Scale API Manufacturing and ..
07/13 CAMBREX : Completes $50 million Investment in Large Scale API Manufacturing and ..
07/12 Cambrex Completes $50 Million Investment in Large Scale API Manufacturing and..
More news
Sector news : Pharmaceuticals - NEC
02:55aDJWALGREENS BOOTS ALLIANCE : Theranos Walks Away From Zika Test
01:33a ASTRAZENECA : to pay $5.52 million to resolve U.S. SEC foreign bribery case
08/30 U.S. slams EU, but Apple tax demand first issued in Washington
08/30DJFDA Approves Novartis's Biosimilar to Amgen's Enbrel
08/30DJNOVARTIS : FDA Approves Novartis's Biosimilar to Amgen's Enbrel
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
08/01 BIOTECH FORUM DAILY DIGEST : The Rally Continues, Finally Some Good News For Ion..
07/31 Cambrex's (CBM) CEO Steven Klosk on Q2 2016 Results - Earnings Call Transcrip..
07/28 Cambrex beats by $0.09, beats on revenue
07/27 Notable earnings before Thursday?s open
07/13 Caterpillar Is A Buy - Cramer's Lightning Round (7/12/16)
Advertisement
Chart CAMBREX CORPORATION
Duration : Period :
Cambrex Corporation Technical Analysis Chart | CBM | US1320111073 | 4-Traders
Full-screen chart
Technical analysis trends CAMBREX CORPORATION
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Average target price 55,4 $
Spread / Average Target 28%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Steven M. Klosk President, Chief Executive Officer & Director
Shlomo Yanai Non-Executive Chairman
Shawn P. Cavanagh Chief Operating Officer & Executive Vice President
Gregory P. Sargen Chief Financial Officer & Executive Vice President
Peter G. Tombros Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CAMBREX CORPORATION-7.84%1 389
JOHNSON & JOHNSON16.31%328 086
PFIZER INC.8.05%212 965
ROCHE HOLDING LTD.-12.84%212 954
NOVARTIS AG-10.83%208 887
MERCK & CO., INC.18.72%174 236
More Results